E5 AI

E5 AI (Element5) develops an agentic automation platform that transforms post-acute healthcare operations by automating complex revenue cycle management (RCM) workflows across the patient financial journey. The company's Neos solution suite provides modular, end-to-end automation spanning patient referral and intake (converting more referrals by connecting portals with EHRs), eligibility and benefit verification (preventing downstream denials through automated checks), prior authorizations (accelerating approvals), claims processing (submitting clean NOAs and Finals), denials management (rapid resolution through automated categorization), and remittance and collections (auto-posting payments and flagging variances). The platform also extends beyond RCM with AI agents for audits and compliance, operations automation (including OASIS and HOPE to iQIES submissions), and custom agent development. E5 AI's agentic architecture breaks goals into sub-tasks executed by specialist agents that communicate across systems, with human-in-the-loop exception handling and full audit trails. The platform is SOC 2 Type II and HIPAA compliant, processes 121,000 transactions per day, achieves 82%+ labor burden reduction, and operates as a fully managed service with 24/7 monitoring. Founded in 2019 and headquartered in San Jose, California, E5 AI has raised $48.5 million in a Series B round backed by Insight Partners and Maxwell Investment Partners.